SE0300586L - Diagnos av autism - Google Patents

Diagnos av autism

Info

Publication number
SE0300586L
SE0300586L SE0300586A SE0300586A SE0300586L SE 0300586 L SE0300586 L SE 0300586L SE 0300586 A SE0300586 A SE 0300586A SE 0300586 A SE0300586 A SE 0300586A SE 0300586 L SE0300586 L SE 0300586L
Authority
SE
Sweden
Prior art keywords
seq
autism
diagnosis
peptides
skithrihwesasll
Prior art date
Application number
SE0300586A
Other languages
English (en)
Swedish (sv)
Other versions
SE0300586D0 (sv
Inventor
Anders Grubb
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0300586A priority Critical patent/SE0300586L/xx
Publication of SE0300586D0 publication Critical patent/SE0300586D0/xx
Priority to RU2005130641/15A priority patent/RU2340900C2/ru
Priority to NZ542149A priority patent/NZ542149A/en
Priority to EP04716392A priority patent/EP1608982B9/de
Priority to ES04716392T priority patent/ES2293234T3/es
Priority to PT04716392T priority patent/PT1608982E/pt
Priority to PCT/SE2004/000193 priority patent/WO2004079371A1/en
Priority to CA2518066A priority patent/CA2518066C/en
Priority to CN2004800058238A priority patent/CN1795386B/zh
Priority to AU2004217571A priority patent/AU2004217571B2/en
Priority to AT04716392T priority patent/ATE371192T1/de
Priority to JP2006507920A priority patent/JP4452715B2/ja
Priority to DE602004008439T priority patent/DE602004008439T2/de
Priority to PL04716392T priority patent/PL1608982T3/pl
Priority to DK04716392T priority patent/DK1608982T3/da
Priority to KR1020057016254A priority patent/KR101096487B1/ko
Priority to BRPI0408067-0A priority patent/BRPI0408067A/pt
Publication of SE0300586L publication Critical patent/SE0300586L/xx
Priority to ZA200507082A priority patent/ZA200507082B/en
Priority to US13/166,143 priority patent/US8268576B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SE0300586A 2003-03-04 2003-03-04 Diagnos av autism SE0300586L (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism
BRPI0408067-0A BRPI0408067A (pt) 2003-03-04 2004-03-02 disgnóstico de autismo
CN2004800058238A CN1795386B (zh) 2003-03-04 2004-03-02 孤独症的诊断
AT04716392T ATE371192T1 (de) 2003-03-04 2004-03-02 Diagnose von autismus
EP04716392A EP1608982B9 (de) 2003-03-04 2004-03-02 Diagnose von autismus
ES04716392T ES2293234T3 (es) 2003-03-04 2004-03-02 Diagnotico del autismo.
PT04716392T PT1608982E (pt) 2003-03-04 2004-03-02 Diagnóstico de autismo
PCT/SE2004/000193 WO2004079371A1 (en) 2003-03-04 2004-03-02 Diagnosis of autism
CA2518066A CA2518066C (en) 2003-03-04 2004-03-02 Diagnosis of autism
RU2005130641/15A RU2340900C2 (ru) 2003-03-04 2004-03-02 Диагностика аутизма
AU2004217571A AU2004217571B2 (en) 2003-03-04 2004-03-02 Diagnosis of autism
NZ542149A NZ542149A (en) 2003-03-04 2004-03-02 Diagnosis of autism by determining the presence or absence of certain proteins/peptides with specific amino acids sequences that have molecular masses of 1779 +/-1 Da, 1865+/-1 Da and 2022+/-1 Da, respectively
JP2006507920A JP4452715B2 (ja) 2003-03-04 2004-03-02 特定のペプチドを自閉症の指標として利用する方法
DE602004008439T DE602004008439T2 (de) 2003-03-04 2004-03-02 Diagnose von autismus
PL04716392T PL1608982T3 (pl) 2003-03-04 2004-03-02 Diagnozowanie autyzmu
DK04716392T DK1608982T3 (da) 2003-03-04 2004-03-02 Diagnose af autisme
KR1020057016254A KR101096487B1 (ko) 2003-03-04 2004-03-02 자폐증의 진단
ZA200507082A ZA200507082B (en) 2003-03-04 2005-09-02 Diagnosis of autism
US13/166,143 US8268576B2 (en) 2003-03-04 2011-06-22 Diagnosis of autism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism

Publications (2)

Publication Number Publication Date
SE0300586D0 SE0300586D0 (sv) 2003-03-04
SE0300586L true SE0300586L (sv) 2004-09-05

Family

ID=20290572

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism

Country Status (19)

Country Link
US (1) US8268576B2 (de)
EP (1) EP1608982B9 (de)
JP (1) JP4452715B2 (de)
KR (1) KR101096487B1 (de)
CN (1) CN1795386B (de)
AT (1) ATE371192T1 (de)
AU (1) AU2004217571B2 (de)
BR (1) BRPI0408067A (de)
CA (1) CA2518066C (de)
DE (1) DE602004008439T2 (de)
DK (1) DK1608982T3 (de)
ES (1) ES2293234T3 (de)
NZ (1) NZ542149A (de)
PL (1) PL1608982T3 (de)
PT (1) PT1608982E (de)
RU (1) RU2340900C2 (de)
SE (1) SE0300586L (de)
WO (1) WO2004079371A1 (de)
ZA (1) ZA200507082B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677556B2 (ja) * 2005-04-22 2011-04-27 国立大学法人 千葉大学 自閉症の診断薬
JP5306345B2 (ja) * 2007-07-26 2013-10-02 フェノメノーム ディスカバリーズ インク 自閉症スペクトラム障害の診断、リスク評価、及びモニタリングを行うための方法
US9347956B2 (en) 2010-12-16 2016-05-24 Autism Biotech Limited Biomarker and uses thereof in diagnosis, treatment of autism
CA2879113C (en) 2012-07-22 2021-11-16 Indiana University Research And Technology Corporation Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd
RU2696481C2 (ru) 2013-10-14 2019-08-02 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Применение акампросата для модулирования активации erk1/2 в животных моделях fxs и asd и людей с диагностированными fxs и asd
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
WO2018164536A1 (ko) 2017-03-10 2018-09-13 스핑고브레인 주식회사 정신장애의 진단 방법
RU2643760C1 (ru) * 2017-08-07 2018-02-05 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Способ определения необходимости использования психофармакотерапии у пациентов с расстройствами аутистического спектра на момент их обследования
KR20190106442A (ko) 2018-03-09 2019-09-18 스핑고브레인 주식회사 태지, 양수 또는 제대혈을 이용한 정신장애의 진단 방법
CN121186361B (zh) * 2025-11-25 2026-04-14 长兴固容生物科技有限公司 一种用于肾癌筛查、诊断的标志物组及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273683A1 (en) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Diagnostic markers for human disorders
IT1303675B1 (it) * 1998-08-04 2001-02-23 Radim S P A Metodo di determinazione di peptidi utilizzati come marker per ladiagnosi dell'autismo
CA2387801A1 (en) 1999-11-04 2001-05-10 Human Genome Sciences, Inc. Uteroglobin-like polynucleotides, polypeptides, and antibodies
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

Also Published As

Publication number Publication date
CN1795386B (zh) 2010-08-25
DE602004008439T2 (de) 2008-05-21
EP1608982B1 (de) 2007-08-22
DE602004008439D1 (de) 2007-10-04
JP4452715B2 (ja) 2010-04-21
RU2340900C2 (ru) 2008-12-10
ATE371192T1 (de) 2007-09-15
ES2293234T3 (es) 2008-03-16
US20120149038A1 (en) 2012-06-14
KR101096487B1 (ko) 2011-12-20
SE0300586D0 (sv) 2003-03-04
AU2004217571A1 (en) 2004-09-16
AU2004217571B2 (en) 2009-03-12
PT1608982E (pt) 2007-11-09
EP1608982A1 (de) 2005-12-28
CA2518066A1 (en) 2004-09-16
RU2005130641A (ru) 2006-02-10
CA2518066C (en) 2011-05-10
PL1608982T3 (pl) 2008-01-31
BRPI0408067A (pt) 2006-02-14
JP2006519391A (ja) 2006-08-24
EP1608982B9 (de) 2008-07-23
KR20060006774A (ko) 2006-01-19
NZ542149A (en) 2008-03-28
WO2004079371A1 (en) 2004-09-16
DK1608982T3 (da) 2007-11-26
ZA200507082B (en) 2007-02-28
CN1795386A (zh) 2006-06-28
US8268576B2 (en) 2012-09-18

Similar Documents

Publication Publication Date Title
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
CY1108689T1 (el) Ολιγοπεπτιδια για την ελαττωση αυξημενης συγκεντρωσεως της ουριας στο αιμα
SE0300586L (sv) Diagnos av autism
WO2002092836A3 (en) Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
WO2002014537A3 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
CN103777013B (zh) 一种检测水中大肠杆菌的微流控芯片以及方法
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
DE60219645D1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
BR0317404A (pt) Variantes do fator xiia
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma
EP1580265A4 (de) Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren
GB0223655D0 (en) Method of diagnosis
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
EP1398378A4 (de) In neuroblastom isolierte nukleinsäuren
ATE420210T1 (de) Diagnose des brustkrebsrisikos
FR2922213B1 (fr) Polymeres a empreintes moleculaires pour la reconnaissance du glutathion gsh, leurs procede de preparation et utilisations
Humphries Microtechniques for the Investigation of Peptidoglycan and Their Application to Bacterial Cell Wall Biochemistry
AU2003240449A1 (en) Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
TH62306A (th) วิธีการตรวจจับและตรวจหาเชิงปริมาณของแบคทีเรียที่ผลิตฮีโมไลซินโดยการตรวจจับและตรวจหาเชิงปริมาณโดยรวมของยีนที่มีเสถียรภาพต่ออุณหภูมิโดยตรงซึ่งเกี่ยวข้องกับฮีโมไลซิน (ยีนสารเป็นพิษที่เกี่ยวข้องกับ tdh) ของแบคทีเรียที่ทำให้อาหารเป็นพิษ

Legal Events

Date Code Title Description
NAV Patent application has lapsed